Found 6 matching trials
A Study to Assess the Efficacy and Safety of AKST4290 With Aflibercept in Patients With Newly Diagnosed nAMD
PHASE2This study will evaluate the efficacy and safety of AKST4290 in combination...
Location
Retina-Vitreous Associates Medical Group
Study Assessing Efficacy and Safety of AKST4290 in Subjects With Parkinson's Disease on Stable Dopaminergic Treatment
PHASE2This study will evaluate the efficacy and safety of AKST4290 in subjects wi...
Location
Atlanta Center for Medical Research
A Study to Evaluate the Efficacy of Oral AKST4290 in Participants With Moderately Severe to Severe Diabetic Retinopathy (CAPRI)
PHASE2A Double-Masked, Placebo-Controlled Study to Evaluate the Efficacy of Oral ...
Evaluate the Effects and Safety of ALK4290 in Patients With Newly Diagnosed Wet Age-Related Macular Degeneration
PHASE2This study will evaluate the therapeutic effects and safety of 800 mg ALK42...
Location
Jahn Ferenc South-Pest Hospital and Clinic
Evaluate the Therapeutic Effects and Safety of ALK4290 in Patients With Refractory Wet Age-Related Macular Degeneration
PHASE2This study will evaluate the therapeutic effects and safety of 800 mg ALK42...
Location
Jahn Ferenc South-Pest Hospital and Clinic
A Study to Assess the Therapeutic Effect and Safety of Adjunctive AKST4290 in Subjects With Bullous Pemphigoid
PHASE2This study will evaluate the therapeutic effect and safety of adjunctive AK...
Location
Universitätsklinikum Carl Gustav Carus Dresden Klinik und Poliklinik für Dermatologie